Search General Info
Search Education
Search Partnering Companies
Rege Nephro Co., Ltd.
4:00 PM - 4:15 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 104A
![BIO International Convention](/sites/default/files/2021-09/_BIO_CONV_Logo-White.png)
Rege Nephro is pre-clinical stage company developing a allogenic cell therapy by human iPS cell-derived nephron progenitor cells (iNPCs) for chronic kidney disease (CKD). iNPCs are differentiated from iPS cells and originally created by Dr. Osafune, a professor of CiRA, Center for iPS Cell Research and Application, Kyoto University. iNPCs are effective for the treatment of pre-clinical CKD models when injected into the kidney. The manufacturing process has been established and the therapy is currently undergoing pre-clinical studies. We are aiming to begin clinical trials in the coming year.
Another pipeline is a small molecule drug for ADPKD, discovered from a disease model reconstituted from patient-derived iPS cells invented from Osafune Lab. Currently, a Phase II clinical trial is planned in this year.
Rege Nephro has been funded by top-tier Japanese venture capital firms and is now seeking business partners for these pipelines and new investors.
Another pipeline is a small molecule drug for ADPKD, discovered from a disease model reconstituted from patient-derived iPS cells invented from Osafune Lab. Currently, a Phase II clinical trial is planned in this year.
Rege Nephro has been funded by top-tier Japanese venture capital firms and is now seeking business partners for these pipelines and new investors.
![](https://778c1607566f28c5e8fd-e6db6de54823ad7fd298e0f6ff75b72a.ssl.cf1.rackcdn.com/BIO_4121_EOISBJNL_266_RegeNephroCoLtd-FileId-328515.jpg)
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
2019
Main Therapeutic Focus:
Regenerative Medicine
Lead Product in Development:
iPS cell-derived nephron progenitor cells
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
![Placeholder Photo](/act-root/bio/assets/images/speaker-default.png)
BIO DOUBLE HELIX SPONSORS
![Sanofi logo](/sites/default/files/2022-05/Sanofi_Color_jpg_Double%20Helix.jpg)
![Eli Lilly and Company](/sites/default/files/2019-09/Eli%20Lilly%20and%20Company.png)
![Amgen logo](/sites/default/files/2022-05/Amgen_Color_png_Double%20Helix.png)
![Genentech logo](/sites/default/files/2022-05/Genentech_Color_png_Double%20Helix.png)
![Merck_logo_2022](/sites/default/files/2022-10/Merck_Color_.png)
![Avantor](/sites/default/files/2021-06/Avantor-BIO-DH-578.png)
![GSK logo](/sites/default/files/2023-04/gsk_color_png.png)
BIO HELIX SPONSORS
![Johnson and Johnson](/sites/default/files/2021-06/Johnson-Johnson-BIO-DH-578.png)
![Takeda logo](/sites/default/files/2022-05/Takeda_Color_jpg_Premier.jpg)
![Travere logo](/sites/default/files/2022-05/Travere_Color_png_Helix%20large.png)
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2024 All Rights Reserved